Peter Mueller

2010

In 2010, Peter Mueller earned a total compensation of $3.7M as EVP, Global R&D Chief Scientific Officer at Vertex Pharmaceuticals, a 60% decrease compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$509,850
Option Awards$2,046,867
Salary$564,596
Stock Awards$566,119
Other$12,495
Total$3,699,927

Mueller received $2M in option awards, accounting for 55% of the total pay in 2010.

Mueller also received $509.9K in non-equity incentive plan, $564.6K in salary, $566.1K in stock awards and $12.5K in other compensation.

Rankings

In 2010, Peter Mueller's compensation ranked 1,538th out of 10,439 executives tracked by ExecPay. In other words, Mueller earned more than 85.3% of executives.

ClassificationRankingPercentile
All
1,538
out of 10,439
85th
Division
Manufacturing
550
out of 3,837
86th
Major group
Chemicals And Allied Products
108
out of 925
88th
Industry group
Drugs
62
out of 684
91st
Industry
Pharmaceutical Preparations
50
out of 480
90th
Source: SEC filing on April 4, 2013.

Mueller's colleagues

We found five more compensation records of executives who worked with Peter Mueller at Vertex Pharmaceuticals in 2010.

2010

Matthew Emmens

Vertex Pharmaceuticals

Chief Executive Officer

2010

Ian Smith

Vertex Pharmaceuticals

Chief Financial Officer

2010

Kenneth Boger

Vertex Pharmaceuticals

Chief Legal Officer

2010

Amit Sachdev

Vertex Pharmaceuticals

Senior Vice President, Corporate Affairs and Public Policy, and Commercial Business Lead, Canada

2010

Nancy Wysenski

Vertex Pharmaceuticals

EVP & Chief Commercial Officer

In-depth

You may also like